Combination of Sotyktu and Enstilar for Plaque Psoriasis

NCT06329258 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Enstilar
DRUG: Deucravacitinib

Sponsor

Psoriasis Treatment Center of Central New Jersey